TAVR in SAVR was durable through 5 years, and TAVR in TAVR was safe and effective through 1 year.
Safety goals were met in the trial, but better efficacy may require ensuring complete coverage of the three major cerebral vessels.
Despite declining over a 10-year span, rates of second CV events remain high, suggesting there’s room for improvement.
Media coverage of several small, CMR studies has led to an uptick in unwarranted CMR requests, says Venkatesh Murthy.
The emphasis is on foods people can and should eat, not foods to avoid, with the ultimate goal of extending CV longevity.
The small series will fuel the contentious debate over the lasting cardiac effects, but everyone agrees: more data are needed.
Separate studies showed how hypertension among infected patients influences adverse outcomes.
In a population under age 35, 20% required ICU care, 10% were put on ventilators, and approximately 3% died.
More-potent antiplatelet therapy should be used with caution in patients older than 80 years, authors suggest.
With a cutoff of Hb ≤ 8 g/dL as the trigger for transfusion, a restrictive strategy was safe and cost-effective.